Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Parrish DeanEVP & Chief Operating Officer | Option exercise | M | — 1,000 sh | Sep 3, 2026 |
| 9 | Malzahn CraigChief Technology Officer | Tax withholding | F | $2,181 234 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Peschard Mijares Guillermo EduardoEVP | Grant or award | A | $248 2 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Cornelius CraigDirector, President & CEO | Grant or award | A | — 4,277 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Parrish DeanEVP & Chief Operating Officer | Option exercise | M | — 1,000 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Bliss KellyPresident, U.S. Group Health | Option exercise | M | — 9,152 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Simon JoshDirector, Chief Executive Officer | Option exercise | M | — 250.0K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Keller FrankPres., Checkout Sol. & Paypal | Option exercise | M | — 6,903 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Swiniarski Keith C.Chief Accounting Officer | Tax withholding | F | $790 121 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Bliss KellyPresident, U.S. Group Health | Option exercise | M | — 4,859 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Barbour BernardChief Tech & Product Officer | Grant or award | A | — 40.0K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Jani RaviChief Financial Officer | Disposition to issuer | D | — 248 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Xu KangCHIEF TECHNOLOGY OFFICER | Tax withholding | F | $18K 35.2K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Paulek Mark DChief Human Resources Officer | Tax withholding | F | $22K 1,661 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 8 | Randhawa SimratEVP, Head of R&D | Open-market sale · 10b5-1 plan | SELL | $273K 2,600 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 8 | Sousa Mauad BrunoDirector | Derivative conversion | C | $406K 4,999 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 8 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $37K 858 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 8 | Sousa Mauad BrunoDirector | Derivative conversion | C | $649K 24.2K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 8 | Mulligan BrendanGeneral Counsel and Secretary | Tax withholding | F | $259K 9,435 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 8 | Ellingson Alan WayneChief Financial Officer | Tax withholding | F | $60K 2,563 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Randhawa SimratEVP, Head of R&D | Option exercise · 10b5-1 plan | M | $136K 6,249 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Rodrigues Fernando M.President of BetterHelp | Option exercise · 10b5-1 plan | M | — 8,717 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Guarini KathrynDirector | Option exercise · 10b5-1 plan | M | — 400 sh | Sep 3, 2026 traded Sep 2, 2026 |
| 7 | Le Pendeven YvesCFO | Open-market sale · 10b5-1 plan | SELL | $12K 1,833 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Smith Kevin P.EVP, Bus Dev, GC & Sec | Tax withholding · 10b5-1 plan | F | $46K 8,671 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Colburn Richard Edward IIIChief Product & Tech Officer | Open-market sale · 10b5-1 plan | SELL | $40K 479 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 7 | Randhawa SimratEVP, Head of R&D | Option exercise · 10b5-1 plan | M | $207K 9,375 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Randhawa SimratEVP, Head of R&D | Option exercise · 10b5-1 plan | M | $134K 7,500 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Rodrigues Fernando M.President of BetterHelp | Option exercise · 10b5-1 plan | M | — 1,042 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Viljoen NataschaDirector, President & CEO | Open-market sale · 10b5-1 plan | SELL | $477K 3,882 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Tuffin PaulaGeneral Counsel and CCO | Grant or award | A | — 6,132 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Kerdman AlinaSVP, Controller & CAO | Option exercise | M | — 408 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Yoon William TChief Legal Officer | Grant or award | A | — 28.9K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Verma ShivChief Financial Officer | Option exercise | M | — 23.6K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Kerdman AlinaSVP, Controller & CAO | Tax withholding | F | $13K 206 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Verma ShivChief Financial Officer | Option exercise | M | — 9,692 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $193K 600 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $59K 1,368 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 5 | Melwani PraveerCFO and Treasurer | Tax withholding | F | $193K 7,037 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 5 | O'Brien Michael GrahamCFO | Option exercise | M | — 214 sh | Sep 3, 2026 traded Sep 1, 2026 |